(FHLC) Fidelity MSCI Health Care - Overview
ETF Category: Health | Exchange: NYSE (USA) | Market Cap: 2.989m USD | Total Return: 17% in 12m
Avg Turnover: 11.8M
Warnings
Extended 3d
Tailwinds
No distinct edge detected
The Fidelity MSCI Health Care Index ETF (FHLC) tracks the MSCI USA IMI Health Care 25/50 Index, targeting the broad U.S. healthcare sector. The fund employs a representative sampling strategy, investing at least 80% of its assets in index securities to replicate the performance of domestic healthcare equities across various market capitalizations.
The healthcare sector is characterized by defensive characteristics and long-term demand driven by an aging global population and continuous pharmaceutical innovation. This specific index utilizes a 25/50 capping methodology to ensure compliance with regulatory concentration limits, preventing any single large-cap constituent from dominating the portfolios risk profile.
Investors can further analyze these sector weightings and valuation metrics on ValueRay. Since its inception in 2013, this non-diversified fund has provided exposure to sub-industries including biotechnology, medical devices, and managed healthcare services.
- Medicare reimbursement rate updates impact health insurer margins
- FDA drug approval cycles drive pharmaceutical and biotech revenue
- GLP-1 weight loss drug demand scales major constituent earnings
- Federal healthcare policy shifts influence medical device pricing power
As of June 08, 2026, the stock is trading at USD 73.44 with a total of 620,593 shares traded.
Over the past week, the price has changed by +1.65%,
over one month by +4.88%,
over three months by -0.04% and
over the past year by +16.97%.
Fidelity MSCI Health Care has no consensus analysts rating.